In this conversation, I will talk with Peter Llewellyn-Davies, CEO of Apeiron and President of Biotech Austria about the Future of Life Science Entrepreneurship and Investment in Europe.
Topics we discuss in the show:
Who is the Expert in the show?
Support the show (https://lsg2g.substack.com/subscribe?)
Video to the Episode
(01:25) How did the Life Science Ecosystem Evolve?
(03:22) The Biontech Success Story
(04:10) How Did The Private and Publice Sector Evolve in Europe Since 2006?
(05:49) What is Biotech Austria’s Mission?
(07:00) How Many Members Does Biotech Austria Have in 2021?
(09:10) Biotech Success Stories From Austria
(11:40) Vienna, Austria, Local Life-Science-Eco-Systems and Biontech’s Success
(13:45) Why is it a Great Decision to Start a Life Science Company in Austria?
(16:26) Where Do Scientists Get Follow On Funding From?
(18:30) How Helpful is the New European Investment Regulation for Foreign Investors?
(21:00) Fundraising Challenges for Life Science Companies
(24:00) Why Life Science Investments Are Attractive
(25:50) How to Get in Touch With Biotech Austria
Podcast Website: https://www.lifescienceget2gether.com/
Community Partner: https://linktr.ee/lsg2g
Christian Soschner: https://linktr.ee/soschner
LSG2G Twitter: https://twitter.com/LGet2gether
LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
Podcast Episodes: https://pod.link/1493847125
Episodes on YouTube: https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV